QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
16.32
-1.18 (-6.72%)
At close: Aug 6, 2026, 4:00 PM EDT
12.85
-3.47 (-21.26%)
After-hours: Aug 6, 2026, 7:14 PM EDT
QuidelOrtho Employees
QuidelOrtho had 6,500 employees as of December 28, 2025. The number of employees decreased by 100 or -1.52% compared to the previous year.
Employees
6,500
Change (1Y)
-100
Growth (1Y)
-1.52%
Revenue / Employee
$411,415
Profits / Employee
-$161,292
Market Cap
1.11B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 28, 2025 | 6,500 | -100 | -1.52% |
| Dec 29, 2024 | 6,600 | -500 | -7.04% |
| Dec 31, 2023 | 7,100 | 100 | 1.43% |
| Jan 1, 2023 | 7,000 | 5,400 | 337.50% |
| Jul 3, 2022 | 6,900 | - | - |
| Jan 2, 2022 | 1,600 | 230 | 16.79% |
| Dec 31, 2020 | 1,370 | 120 | 9.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Enovis | 7,802 |
| Integra LifeSciences Holdings | 4,427 |
| CONMED | 3,900 |
| Tandem Diabetes Care | 2,500 |
| Artivion | 1,800 |
| Bioventus | 940 |
| Alphatec Holdings | 913 |
| PROCEPT BioRobotics | 888 |
QDEL News
- 2 hours ago - QuidelOrtho Earnings Call Transcript: Q2 2026 - Transcripts
- 2 hours ago - QuidelOrtho Earnings release: Q2 2026 - Filings
- 3 hours ago - QuidelOrtho reports Q2 adjusted EPS 13c, consensus (5c) - TheFly
- 3 hours ago - QuidelOrtho cuts FY26 adjusted EPS view to 65c-90c from $1.80-$2.00 - TheFly
- 3 hours ago - QuidelOrtho Reports Second Quarter 2026 Financial Results - PRNewsWire
- 13 days ago - QuidelOrtho to Report Second Quarter 2026 Financial Results - PRNewsWire
- 14 days ago - Beyond Fentanyl: How the Drug Crisis Is Changing - PRNewsWire
- 22 days ago - QuidelOrtho Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire